NXGLW
NEXGEL, INC.
Key Financials
Gross Profit
$4.5M
↑ 64.1%
Revenue
$11.4M
↑ 31.5%
Operating Income
$-3352000
↑ 5.7%
EPS (Diluted)
$-0.38
↑ 24.0%
Total Liabilities
$5.6M
↑ 13.6%
Shareholders' Equity
$4.5M
↓ 22.5%
Net Income
$-3000000
↑ 8.6%
Total Assets
$10.5M
↓ 4.8%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 5/18/2026 | View on SEC |
| 4 | 5/18/2026 | View on SEC |
| 4 | 5/18/2026 | View on SEC |
| 3 | 5/18/2026 | View on SEC |
| 3 | 5/18/2026 | View on SEC |
| 8-K | 5/15/2026 | View on SEC |
| 10-Q | 5/14/2026 | View on SEC |
| 8-K | 5/12/2026 | View on SEC |
| 3 | 5/7/2026 | View on SEC |
| 10-K/A | 4/30/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | NXGLW |
| Company Name | NEXGEL, INC. |
| CIK | 1468929 |
| Sector | Surgical & Medical Instruments & Apparatus |
| Industry | Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 3841 |
| SIC Description | Surgical & Medical Instruments & Apparatus |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 215 702-8550 |